Rappel de Fortify Assura

Selon U.S. Food and Drug Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à United States qui a été fabriqué par St Jude Medical Inc..

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
  • ID de l'événement
  • Classe de risque de l'événement
    Class 2
  • Numéro de l'événement
  • Date de mise en oeuvre de l'événement
  • Statut de l'événement
    Open, Classified
  • Pays de l'événement
  • Source de l'événement
  • URL de la source de l'événement
  • Notes / Alertes
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notes supplémentaires dans les données
    Implantable cardioverter defibrillator (non-CRT) - Product Code LWS
  • Cause
    The firm is releasing new firmware for high voltage implantable cardiac devices (icd) and cardiac resynchronization therapy defibrillators (crt-d) intended to strengthen security by providing an additional layer of protection against unauthorized device access. for older generation devices not capable of accepting the firmware, the firm is advising customers of the option to permanently disable the rf communication capability in these devices.
  • Action
    On 04/16/2018, Important Medical Device Advisory notifications were mailed via overnight service to U.S. physicians and hospitals notifying customers of the availability of the programmer software update and associated ICD/CRT-D firmware update. Advisory notifications were mailed to customers outside the U.S. on different dates depending on geography and local regulatory requirements. Prophylactic replacement of affected devices is not recommended. The firm recommends firmware upgrades for all eligible patients at the next regularly scheduled visit or when appropriate depending on the preferences of the patient and physician. For devices not eligible for the cybersecurity firmware update the firm recommends a discussion of the risks of cybersecurity vulnerabilities and proven benefits of remote monitoring with patients at their next regularly scheduled visit. RF communication may be permanently disabled in devices not eligible for firmware updates during an in-clinic device interrogation with a programmer that has received the software update. Customers with questions about the firmware update can call the customer technical support hotline at 1-800-436-5056.


  • Modèle / numéro de série
  • Classification du dispositif
  • Classe de dispositif
  • Dispositif implanté ?
  • Distribution
    U.S. Nationwide distribution
  • Description du dispositif
    Fortify Assura, Sterile EO, Model #/ Part #: || CD1257-40/100042322, 100059623; || CD1257-40Q/100042341, 100059535; || CD1259-40/100041914, 100042338, 100059536, 100059646, 100081567; || CD1259-40Q/100041931, 100042339, 100059537, 100059620, 100059626, 100078685; || CD1263-40/100042948; || CD1263-40Q/100042949; || CD1357-40C/100080365, 100080377, 100083441; || CD1357-40Q/100080389, 100080390, 100083388; || CD1359-40/100078740, 100083267, 100096839; || CD1359-40C/100078500, 100078969, 100079372, 100079373, 100083442, 100083443, 100117545; || CD1359-40Q/100078804, 100079155, 100079413, 100083445, 100096884; || CD1359-40QC/100078603, 100079145, 100079146, 100079239, 100083405, 100083444, 100117632, 100127000, 100127065; || CD1363-40C/100080349; || CD1363-40Q/100080317; || CD1391-40C/100080756; || CD1391-40QC/100080783; || CD2257-40/100042337, 100059839; || CD2257-40Q/100042342, 100059842; || CD2259-40/100041893, 100042308, 100059794, 100059907, 100082567; || CD2259-40Q/100041894, 100042309, 100059845, 100059873, 100078610; || CD2263-40/100042950; || CD2263-40Q/100043201; || CD2357-40C/100080404, 100080413, 100083490; || CD2357-40Q/100080319, 100080412, 100083492; || CD2359-40/100078750, 100083466; || CD2359-40C/100078651, 100079201, 100079240, 100079442, 100083501, 100083502, 100117546; || CD2359-40Q/100078841, 100079109, 100083472; || CD2359-40QC/100078652, 100079156, 100079157, 100079337, 100083407, 100083465, 100117580, 100127092, 100127103; || CD2363-40C/100080416; || CD2363-40Q/100080407; || CD2391-40C/100080784; || CD2391-40QC/100080744
  • Manufacturer


  • Adresse du fabricant
    St Jude Medical Inc., 15900 Valley View Ct, Sylmar CA 91342-3577
  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source